|
|
||||||||

Departments of
*
Pathology and
Microbiology and Immunology and
Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322
We recently identified the immunodominant epitope for polyoma virus-specific CTL as the Dk-associated peptide MT389397 derived from the middle T (MT) viral oncoprotein. Another Dk-restricted peptide corresponding to residues 236244 of MT was recognized by nearly all MT389397-reactive CTL clones, but required concentrations at least 2 logs higher to sensitize syngeneic target cells for lysis. Except for identity at the three putative Dk-peptide anchor residues, MT236244 shares no homology with MT389397. Using a novel europium-based class I MHC-peptide binding immunoassay, we determined that MT236244 bound Dk 23 logs less well than MT389397. Infection with a mutant polyoma virus whose MT is truncated just before the MT389397 epitope or immunization with MT389397 or MT236244 peptides elicited CTL that recognized both MT389397 and MT236244. Importantly, infection with a polyoma virus lacking MT389397 and mutated in an MT236244 Dk anchor position induced polyoma virus-specific CTL recognizing neither MT389397 nor MT236244 epitopes. Despite predominant usage of the Vß6 gene segment, MT389397/MT236244 cross-reactive CTL clones possess diverse complementarity-determining region 3ß domains; this is functionally reflected in their heterogeneous recognition patterns of alanine-monosubstituted MT389397 peptides. Using Dk/MT389397 tetramers, we directly visualized MT236244 peptide-induced TCR down-modulation of virtually all MT389397-specific CD8+ T cells freshly explanted from polyoma-infected mice, suggesting that a single TCR recognizes both Dk-restricted epitopes. The availability of immunodominant epitope-specific CTL capable of recognizing a second epitope in MT, a viral protein essential for tumorigenesis, may serve to amplify the CTL response to the immunodominant epitope and prevent the emergence of immunodominant epitope-loss viruses and virus-induced tumors.
This article has been cited by other articles:
![]() |
P. A. Swanson II, C. D. Pack, A. Hadley, C.-R. Wang, I. Stroynowski, P. E. Jensen, and A. E. Lukacher An MHC class Ib-restricted CD8 T cell response confers antiviral immunity J. Exp. Med., July 7, 2008; 205(7): 1647 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Byers, N. P. Andrews, and A. E. Lukacher CD94/NKG2A Expression Is Associated with Proliferative Potential of CD8 T Cells during Persistent Polyoma Virus Infection J. Immunol., May 15, 2006; 176(10): 6121 - 6129. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oh, M. Terabe, C. D. Pendleton, A. Bhattacharyya, T. K. Bera, M. Epel, Y. Reiter, J. Phillips, W. M. Linehan, C. Kasten-Sportes, et al. Human CTLs to Wild-Type and Enhanced Epitopes of a Novel Prostate and Breast Tumor-Associated Protein, TARP, Lyse Human Breast Cancer Cells Cancer Res., April 1, 2004; 64(7): 2610 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Brehm, T. G. Markees, K. A. Daniels, D. L. Greiner, A. A. Rossini, and R. M. Welsh Direct Visualization of Cross-Reactive Effector and Memory Allo-Specific CD8 T Cells Generated in Response to Viral Infections J. Immunol., April 15, 2003; 170(8): 4077 - 4086. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rubio-Godoy, V. Dutoit, Y. Zhao, R. Simon, P. Guillaume, R. Houghten, P. Romero, J.-C. Cerottini, C. Pinilla, and D. Valmori Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL J. Immunol., November 15, 2002; 169(10): 5696 - 5707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Constantin, E. E. Bonney, J. D. Altman, and O. L. Strickland Major Histocompatibility Complex (MHC) Tetramer Technology: An Evaluation Biol Res Nurs, October 1, 2002; 4(2): 115 - 127. [Abstract] [PDF] |
||||
![]() |
M. Lomas, E. Hanon, Y. Tanaka, C. R. M. Bangham, and K. G. Gould Presentation of a new H-2Dk-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin J. Gen. Virol., March 1, 2002; 83(3): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Messaoudi, J. LeMaoult, B. M. Metzner, M. J. Miley, D. H. Fremont, and J. Nikolich-Zugich Functional Evidence That Conserved TCR CDR{{alpha}}3 Loop Docking Governs the Cross-Recognition of Closely Related Peptide:Class I Complexes J. Immunol., July 15, 2001; 167(2): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tourdot, S. Herath, and K. G. Gould Characterization of a new H-2Dk-restricted epitope prominent in primary influenza A virus infection J. Gen. Virol., July 1, 2001; 82(7): 1749 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Regner, M. Lobigs, R. V. Blanden, P. Milburn, and A. Mullbacher Antiviral Cytotoxic T Cells Cross-Reactively Recognize Disparate Peptide Determinants from Related Viruses but Ignore More Similar Self- and Foreign Determinants J. Immunol., March 15, 2001; 166(6): 3820 - 3828. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Moser, J. D. Altman, and A. E. Lukacher Antiviral Cd8+ T Cell Responses in Neonatal Mice: Susceptibility to Polyoma Virus-Induced Tumors Is Associated with Lack of Cytotoxic Function by Viral Antigen-Specific T Cells J. Exp. Med., March 5, 2001; 193(5): 595 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Lukacher, J. M. Moser, A. Hadley, and J. D. Altman Visualization of Polyoma Virus-Specific CD8+ T Cells In Vivo During Infection and Tumor Rejection J. Immunol., September 15, 1999; 163(6): 3369 - 3378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |